Tigchelaar Celien, Atmosoerodjo Sawal D, van Faassen Martijn, Wardenaar Klaas J, De Deyn Peter P, Schoevers Robert A, Kema Ido P, Absalom Anthony R
Department of Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ann Transl Med. 2021 Mar;9(6):455. doi: 10.21037/atm-20-4498.
The pathophysiology of numerous central nervous system disorders remains poorly understood. Biomarker research using cerebrospinal fluid (CSF) is a promising way to illuminate the neurobiology of neuropsychiatric disorders. CSF biomarker studies performed so far generally included patients with neurodegenerative diseases without an adequate control group. The Anaesthetic Biobank of Cerebrospinal fluid (ABC) was established to address this. The aims are to (I) provide healthy-control reference values for CSF-based biomarkers, and (II) to investigate associations between CSF-based candidate biomarkers and neuropsychiatric symptoms.
In this cross-sectional study, we collect and store CSF and blood from adult patients undergoing spinal anaesthesia for elective surgery. Blood (20.5 mL) is collected during intravenous cannulation and CSF (10 mL) is aspirated prior to intrathecal local anaesthetic injection. A portion of the blood and CSF is sent for routine laboratory analyses, the remaining material is stored at -80 °C. Relevant clinical, surgical and anaesthetic data are registered. A neurological examination and Montreal Cognitive Assessment (MoCA) are performed pre-operatively and a subset of patients fill in questionnaires on somatic and mental health (depression, anxiety and stress).
Four-hundred-fifty patients (58% male; median age: 56 years) have been enrolled in the ABC. The planned spinal anaesthetic procedure was not attempted for various reasons in eleven patients, in fourteen patients the spinal puncture failed and in twelve patients CSF aspiration was unsuccessful. A mean of 9.3 mL CSF was obtained in the remaining 413 of patients. Most patients had a minor medical history and 60% scored in the normal range on the MoCA (median score: 26).
The ABC is an ongoing biobanking project that can contribute to CSF-based biomarker research. The large sample size with constant sampling methods and extensive patient phenotyping provide excellent conditions for future neuroscientific research.
众多中枢神经系统疾病的病理生理学仍未得到充分理解。利用脑脊液(CSF)进行生物标志物研究是阐明神经精神疾病神经生物学的一种有前景的方法。迄今为止进行的脑脊液生物标志物研究通常纳入患有神经退行性疾病的患者,而没有足够的对照组。脑脊液麻醉生物样本库(ABC)的建立就是为了解决这一问题。其目的是:(I)为基于脑脊液的生物标志物提供健康对照参考值;(II)研究基于脑脊液的候选生物标志物与神经精神症状之间的关联。
在这项横断面研究中,我们收集并储存接受择期手术脊髓麻醉的成年患者的脑脊液和血液。在静脉置管期间采集血液(20.5 mL),并在鞘内注射局部麻醉剂之前抽取脑脊液(10 mL)。一部分血液和脑脊液送去进行常规实验室分析,其余样本储存在-80°C。记录相关的临床、手术和麻醉数据。术前进行神经系统检查和蒙特利尔认知评估(MoCA),并且一部分患者填写关于躯体和心理健康(抑郁、焦虑和压力)的问卷。
450名患者(58%为男性;中位年龄:56岁)被纳入ABC。由于各种原因,11名患者未尝试计划的脊髓麻醉程序,14名患者脊髓穿刺失败,12名患者脑脊液抽取未成功。其余413名患者平均获得9.3 mL脑脊液。大多数患者有轻微病史,60%的患者MoCA评分在正常范围内(中位评分:26)。
ABC是一个正在进行的生物样本库项目,可为基于脑脊液的生物标志物研究做出贡献。采用恒定采样方法的大样本量和广泛的患者表型分析为未来的神经科学研究提供了良好条件。